All lobbying filings

MEDICAL DEVICE MANUFACTURERS ASSOCIATION

MEDICAL DEVICE MANUFACTURERS ASSOCIATION filed a Q2 report for MEDICAL DEVICE MANUFACTURERS ASSOCIATION on July 18, 2025.

Lobbying for MEDICAL DEVICE MANUFACTURERS ASSOCIATION

All filings by MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Everything MEDICAL DEVICE MANUFACTURERS ASSOCIATION has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 18, 2025

Expenses

$300,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 7

Issues relating to the STRONGER Patents Act and Section 101 reform

Small Business

Issues related to the reauthorization of the Small Business Innovation Research (SBIR) Program

Health Issues

Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation and reimbursement of artificial intelligence in healthcare Issues related to FDA's third party review program Issues related to HR 5662/S 2907 - the Medical Device Recall Improvement Act

Medicare/Medicaid

Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to Medicare coverage for digital health technologies Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures Issues related to S 1717

Taxation/Internal Revenue Code

Issues related to R&D tax credit, bonus depreciation, and interest deductability

Trade (domestic/foreign)

Issues related to trade and tariffs Issues related to United States-Mexico-Canada Agreement (USMCA)

Budget/Appropriations

Issues related to appropriations and user fee funding for the Food and Drug Administration

Bills named in this filing 4

H.R. 3723
Medical Device Electronic Labeling Act
H.R. 2369
VALID Act of 2023
H.R. 5662
Medical Device Recall Improvement Act
H.R. 1691
Ensuring Patient Access to Critical Breakthrough Products Act of 2024

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.